Sep 29, 2023 | Past Events
Dr. Mattia Matasci is giving a presentation entitled “Philogen’s Platform for the Development of Immunocytokines”. Follow the link for more detailsSep 29, 2023 | Past Events
Dr. Roberto De Luca will give a talk entitled “Tripokin: Best-in-Class potential for tumor targeted Interleukin-2 (IL2) potentiated by Tumor Necrosis Factor (TNF)” (16th of November, 08:30 pm local time). Follow the link for more details.Sep 29, 2023 | Past Events
Dr. Samuele Cazzamalli (Head of Chemistry) will give a talk entitled “Small Molecule Therapeutics Targeting Fibroblast Activation Protein in the Tumor Microenvironment” (16th of November, 16.45pm local time). Follow the link for more details.Aug 22, 2023 | Past Events
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on August 25th, entitled “From encoded libraries to targeted therapeutics ”. Aureliano Zana (third year PhD student) is giving a presentation on the August 23th entitled “ Small Molecule-Drug Conjugates...Jun 5, 2023 | Past Events
Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, will host a 1-hour live webcast and conference call for analysts on 5 June 2023 at 11:00 ET / 16:00 BST / 17:00 CEST. The...May 31, 2023 | Past Events
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 6th of June 2023 entitled “Immunocytokines with Activity on Demand”. Dr. Roberto De Luca (Head of Antibody Therapeutics) is giving a presentation on the 7th of June 2023 entitled “Engineering...
Recent Comments